Search for a trial

A Phase 3, Prospective, Open-Label, Multisite, Extension of Phase 3 Studies to Assess the Long-Term Safety and Tolerability of Soticlestat as Adjunctive Therapy in Subjects With Dravet Syndrome or Lennox-Gastaut Syndrome (ENDYMION 2)

This study has been transitioned to CTIS with ID 2022-502802-34-00 check the CTIS register for the current data. Primary Objective:To assess the long-term safety and tolerability of soticlestat when administered as adjunctive therapy to standard of…